Research Papers:
Combinatorial effects of an epigenetic inhibitor and ionizing radiation contribute to targeted elimination of pancreatic cancer stem cell
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1803 views | HTML 3590 views | ?
Abstract
Hyun-Mi Kwon1,*, Eun-Jin Kang1,*, Keunsoo Kang2, Sung-Dae Kim1, Kwangmo Yang1 and Joo Mi Yi1
1Research Center, Dongnam Institute of Radiological & Medical Sciences (DIRAMS), Busan 46033, South Korea
2Department of Microbiology, Dankook Universty, Cheonan 31116, South Korea
*These authors have contributed equally to this work
Correspondence to:
Joo Mi Yi, email: [email protected]
Keywords: DNA methylation inhibitor, radiation, pancreatic cancer, cancer stem cell
Received: June 29, 2017 Accepted: August 27, 2017 Published: October 06, 2017
ABSTRACT
Pancreatic cancer is associated with a high mortality rate, owing to de novo and acquired drug resistance, thereby leading to highly invasive and metastatic pancreatic cancer cells. Therefore, targeting pancreatic cancer stem cells (CSCs) may be a novel therapeutic strategy for the treatment of pancreatic cancer. Here, we combined a DNA methylation inhibitor (5-aza-2’-deoxycytidine; 5-aza-dC) and ionizing radiation (IR) to improve anti-cancer effects by inhibiting growth and proliferation and promoting apoptosis of pancreatic cancer cells in vitro and in vivo. Importantly, the combinatorial effect of 5-aza-dC with IR on sphere-forming pancreatic cancer cells was preferentially targeted toward CSCs through the downregulation of regulatory factors of self-renewal and CSC surface markers. We next performed the RNA sequencing to understand the underlying cellular mechanisms of the combined treatment with IR and 5-aza-dC in pancreatic cancer cells. Global transcriptome profiling indicated that the expression of the Oct4-centered transcriptional network of genes was significantly downregulated in cells with combination treatment. Our data suggested that combination treatment with DNA methylation inhibitor and IR may be a novel therapeutic strategy for pancreatic cancer. Overall, these findings support the use of epigenetic therapy in combination with radiotherapy to improve therapeutic efficacy by targeting and eradicating pancreatic CSCs.
![Creative Commons License](/images/80x15.png)
PII: 21642